RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+7.3%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.5B
AUM Growth
+$1.5B
(+5.6%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
31.43%
Holding
99
New
7
Increased
27
Reduced
26
Closed
7
Top Buys
| 1 |
Boston Scientific
BSX
|
$14.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12.8M |
| 3 |
Danaher
DHR
|
$11.8M |
| 4 |
Inspire Medical Systems
INSP
|
$10.7M |
| 5 |
Align Technology
ALGN
|
$9.93M |
Top Sells
| 1 |
Abbott
ABT
|
$14.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
$10.6M |
| 3 |
Elevance Health
ELV
|
$10.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$8.92M |
| 5 |
Biogen
BIIB
|
$8.4M |
Sector Composition
| 1 | Healthcare | 97.82% |
| 2 | Industrials | 1.29% |
| 3 | Technology | 0.26% |
